Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-04-12 @ 2:01 PM
Study NCT ID:
NCT06263959
Status:
RECRUITING
Last Update Posted:
2025-03-05
First Post:
2024-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Sponsor:
Fujian Akeylink Biotechnology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GST-HG131-II-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None